As stated above, SGLT-2 inhibitors exert a number of effects that can be beneficial for patients with acute HF: they induce osmotic diuresis and natriuresis, decrease plasma volume status and interstitial fluid volume, which is expanded in HF, reduce blood pressure, and provoke hemoconcentration. The gene discussed is SLC5A2; the disease is hydrops fetalis.